Your browser doesn't support javascript.
loading
Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthma.
Busse, William W; Humbert, Marc; Haselkorn, Tmirah; Ortiz, Benjamin; Trzaskoma, Benjamin L; Stephenson, Patricia; Garcia Conde, Lorena; Kianifard, Farid; Holgate, Stephen T.
Afiliação
  • Busse WW; University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. Electronic address: wwb@medicine.wisc.edu.
  • Humbert M; Université Paris-Sud, Paris, France.
  • Haselkorn T; EpiMetrix, Inc., Los Altos, California.
  • Ortiz B; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Trzaskoma BL; Genentech, Inc., South San Francisco, California.
  • Stephenson P; Rho, Inc., Chapel Hill, North Carolina.
  • Garcia Conde L; Novartis Pharma AG, Basel, Switzerland.
  • Kianifard F; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Holgate ST; University of Southampton, Southampton, United Kingdom.
Ann Allergy Asthma Immunol ; 124(2): 190-196, 2020 02.
Article em En | MEDLINE | ID: mdl-31760132
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Eosinófilos / Omalizumab Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Eosinófilos / Omalizumab Idioma: En Ano de publicação: 2020 Tipo de documento: Article